FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ted Burns

Research Profile

Disorders

Concepts & Ideas

Physiology

Neural Conduction

Procedures

Activities & Behaviors

Chemicals & Drugs

Glutamate Decarboxylase

Co-author Network

Publications

TOP 3
Ted M Burns
The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.
Ted M Burns
More than meets the eye: the benefits of listening closely to what our patients with myasthenia gravis are telling us.
Ted M Burns; Christopher D Graham; Michael R Rose; Zachary Simmons
Quality of life and measures of quality of life in patients with neuromuscular disorders.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ted Burns (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ted M Burns
The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.
Annals of the New York Academy of Sciences 2012;1274():99-106.
2012: Ted M Burns
More than meets the eye: the benefits of listening closely to what our patients with myasthenia gravis are telling us.
Muscle & nerve 2012;46(2):153-4.
2012: Ted M Burns; Christopher D Graham; Michael R Rose; Zachary Simmons
Quality of life and measures of quality of life in patients with neuromuscular disorders.
Muscle & nerve 2012;46(1):9-25.
2012: Reza Sadjadi; Donald B Sanders; Ted M Burns; Mark Conaway; Gary R Cutter
Psychometric evaluation of the myasthenia gravis composite using Rasch analysis.
Muscle & nerve 2012;45(6):820-5.
2011: Srikanth Muppidi; Gil I Wolfe; Ted M Burns; Mark Conaway
MG-ADL: still a relevant outcome measure.
Muscle & nerve 2011;44(5):727-31.
2011: Ted M Burns; Michelle L Mauermann
The evaluation of polyneuropathies.
Neurology 2011;76(7 Suppl 2):S6-13.
2011: Ted M Burns; C K Grouse; Gil I Wolfe; MR Conaway; Donald B Sanders
The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis.
Muscle & nerve 2011;43(1):14-8.
2010: Ted M Burns
History of outcome measures for myasthenia gravis.
Muscle & nerve 2010;42(1):5-13.
2010: Ted M Burns; Mark Conaway; Donald B Sanders
The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
Neurology 2010;74(18):1434-40.
2010: Michael K Hehir; Ted M Burns; Joshua Alpers; MR Conaway; Michael Sawa; Donald B Sanders
Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
Muscle & nerve 2010;41(5):593-8.
2010: Ted M Burns; C K Grouse; MR Conaway; Donald B Sanders
Construct and concurrent validation of the MG-QOL15 in the practice setting.
Muscle & nerve 2010;41(2):219-26.
2010: Rasheed A Balogun; Andre Kaplan; David M Ward; Chidi Okafor; Ted M Burns; A Sergio Torloni; B Gail Macik; Emaad M Abdel-Rahman
Clinical applications of therapeutic apheresis.
Journal of clinical apheresis 2010;25(5):250-64.
2009: Dawit G Aregawi; Jonathan H Sherman; Mike Douvas; Ted M Burns; David Schiff
Case of the month: leukemic nerve infiltration.
Muscle & nerve 2009;39(3):413-4.
2008: Ted M Burns; Mark R Conaway; Gary R Cutter; Donald B Sanders
Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.
Muscle & nerve 2008;38(6):1553-62.
2008: Dawit G Aregawi; Jonathan H Sherman; Mike Douvas; Ted M Burns; David Schiff
Neuroleukemiosis: case report of leukemic nerve infiltration in acute lymphoblastic leukemia.
Muscle & nerve 2008;38(3):1196-200.
2008: Ted M Burns; Mark R Conaway; Gary R Cutter; Donald B Sanders
Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.
Muscle & nerve 2008;38(2):957-63.
2008: Ted M Burns
Guillain-Barré syndrome.
Seminars in neurology 2008;28(2):152-67.
2008: Michelle L Mauermann; Ted M Burns
The evaluation of chronic axonal polyneuropathies.
Seminars in neurology 2008;28(2):133-51.
2008: Ted M Burns
Neuromuscular disorders. Preface.
Seminars in neurology 2008;28(2):131-2.
2008: Hua Wang; Kylyana S Larriviere; Kristen E Keller; Kathleen A Ware; Ted M Burns; Mark A Conaway; David Lacomis; Gary L Pattee; Lawrence H Phillips; Nina J Solenski; Sasha Zivkovic; James P Bennett
R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008;9(1):50-8.
2007: Juliana Lockman; Ted M Burns
Stiff-person syndrome.
Current treatment options in neurology 2007;9(3):234-40.
2007: Ted M Burns
The forecast for podcasts: sunny skies but not necessarily with clear visibility.
Neurology 2007;68(15):E19-20.
2007: Juliana Lockman; Ted M Burns
Stiff-person syndrome.
Practical neurology 2007;7(2):106-8.
2007: Elliot L Dimberg; Sheila E Crowe; Joel M Trugman; Russell H Swerdlow; M Beatriz S Lopes; T David Bourne; Ted M Burns
Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm.
Movement disorders : official journal of the Movement Disorder Society 2007;22(3):407-11.
2007: Ted M Burns; Gregory A Schaublin; P James B Dyck
Vasculitic neuropathies.
Neurologic clinics 2007;25(1):89-113.
2006: Nikolaus R McFarland; Ivan S Login; Samuel Vernon; Ted M Burns
Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia.
Neurology 2006;67(7):1308-9.
2006: Jeffrey Murray Burns; Michelle L Mauermann; Ted M Burns
An easy approach to evaluating peripheral neuropathy.
The Journal of family practice 2006;55(10):853-61.
2006: Ted M Burns; Lawrence H Phillips; Elliot L Dimberg; Barry K Vaught; Christopher J Klein
Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy.
Neuromuscular disorders : NMD 2006;16(5):308-10.
2005: Greg A Schaublin; Clement J Michet; P James B Dyck; Ted M Burns
An update on the classification and treatment of vasculitic neuropathy.
Lancet neurology 2005;4(12):853-65.
2005: Jeffrey J Tramonte; Ted M Burns
Myotonic dystrophy.
Archives of neurology 2005;62(8):1316-9.
2005: Mohamed Falah; David Schiff; Ted M Burns
Neuromuscular complications of cancer diagnosis and treatment.
The journal of supportive oncology 2005;3(4):271-82.
2005: Ted M Burns; René H M Te Morsche; J B M J Jansen; Joost P H Drenth
Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.
The British journal of dermatology 2005;153(1):174-7.
2005: Elliot L Dimberg; Ted M Burns
Management of common neurologic conditions in sports.
Clinics in sports medicine 2005;24(3):637-62, ix.
2005: Ted M Burns
A step forward for stiff-person syndrome.
Lancet 2005;365(9468):1365-7.
2005: Ted M Burns; Lawrence H Phillips; H Royden Jones
Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies.
Neurology 2005;64(2):399-400; author reply 399-400.
2004: Ted M Burns
Chronic inflammatory demyelinating polyradiculoneuropathy.
Archives of neurology 2004;61(6):973-5.
2004: Carol L Cameron; Peter B Kang; Ted M Burns; Basil T Darras; H Royden Jones
Multifocal slowing of nerve conduction in metachromatic leukodystrophy.
Muscle & nerve 2004;29(4):531-6.
2003: Ted M Burns; H Royden Jones; Lawrence H Phillips; T L Bugawan; Henry A Erlich; V A Lennon
Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter.
Neurology 2003;61(9):1291-3.
2003: Ted M Burns; Susana Quijano-Roy; H Royden Jones
Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.
Neurology 2003;61(6):873; author reply 873.
2003: Ted M Burns
Neurosarcoidosis.
Archives of neurology 2003;60(8):1166-8.
2003: Ted M Burns; Monique M Ryan; Basil T Darras; H Royden Jones
Current therapeutic strategies for patients with polyneuropathies secondary to inherited metabolic disorders.
Mayo Clinic proceedings. Mayo Clinic 2003;78(7):858-68.
2003: Ted M Burns; James A Russell; Daniel H LaChance; H Royden Jones
Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome.
Annals of neurology 2003;53(2):270-3.
2002: Christopher J Klein; P James B Dyck; S M Friedenberg; Ted M Burns; A J Windebank; P J Dyck
Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy.
Journal of neurology, neurosurgery, and psychiatry 2002;73(1):45-50.
2001: Ted M Burns; Bassel F Shneker; Vern C Juel
Gasoline sniffing multifocal neuropathy.
Pediatric neurology 2001;25(5):419-21.
2001: Stuart C Apfel; A K Asbury; Vera Bril; Ted M Burns; James N Campbell; CH Chalk; P James B Dyck; P J Dyck; Eva L Feldman; Howard Fields; I A Grant; John W Griffin; Christopher J Klein; U Lindblom; William J Litchy; P A Low; M Melanson; J R Mendell; M D Merren; Peter C O'Brien; M Rendell; Robert A Rizza; F J Service; P K Thomas; D Walk; A K Wang; K Wessel; Anthony J Windebank; Dan Ziegler; D W Zochodne
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
Journal of the neurological sciences 2001;189(1-2):3-5.
2001: Ted M Burns; N D Lawn; P A Low; M Camilleri; E F Wijdicks
Adynamic ileus in severe Guillain-Barré syndrome.
Muscle & nerve 2001;24(7):963-5.
1999: Ted M Burns; Vern C Juel; Donald B Sanders; Lawrence H Phillips
Neuroendocrine lung tumors and disorders of the neuromuscular junction.
Neurology 1999;52(7):1490-1.